Participated · Series E · Jul 2025

Swift Navigation offers Skylark, a real-time cloud-based precise positioning service that corrects GNSS errors to deliver centimeter-level accuracy for high-volume applications. Skylark is designed for mass-market adoption and operates entirely in the cloud without the need for expensive physical data centers. The service is certified to meet ISO 26262:2018 functional safety standards for road vehicles. Swift reports that Skylark supports over 10 million ADAS-enabled and autonomous vehicles and contributes to global programs for more than 20 automotive OEMs and leading robotics companies. With the new funding, Swift plans to expand adoption across use cases including digital mapping and precision mobile navigation. Timothy Harris is cited as Co-Founder and CEO in the announcement. Swift Navigation offers a comprehensive GNSS platform used across automotive, industrial, and consumer markets. Its products include Skylark, a global wide-area cloud-based GNSS precise positioning service, and Starling, a receiver-agnostic client software positioning engine, along with a variety of Swift and third-party compatible receivers. The platform supports single- and multi-frequency, multi-constellation automotive and commercial-grade GNSS measurement engines and chipsets. Use cases include improved mobile phone positioning (navigation, traffic, augmented reality), continent-wide rail tracking and safety, and enhanced RTK for machine control and guidance in agriculture, construction, and robotics. Customers include automotive OEMs and Tier 1 suppliers, last-mile delivery providers, mobile handset and application companies, and builders of rail, industrial machine control, and IoT platforms. The company intends to use new funding to accelerate growth and expand operations, and to date has raised over $200 million in funding. Swift Navigation builds GNSS and precise positioning technology, including the cloud-based Skylark precise positioning service, the receiver-agnostic Starling software positioning engine, and RTK hardware such as Piksi Multi and Duro devices. Its platform delivers centimeter-accurate, continent-scale positioning across the U.S., Europe, Japan, South Korea, Australia and a growing number of countries. Customers include automotive OEMs, last-mile delivery providers, mobile providers and makers of rail, industrial, micromobility and IoT platforms. The company emphasizes integration with automotive sensor suites and mobile devices to enable lane-level accuracy with privacy and security. Swift plans to use the Series C proceeds to scale customer deployments and continue worldwide expansion. To date the company has raised $97.6 million in funding. Swift Navigation is a San Francisco-based company founded in 2012 by Timothy Harris that develops centimeter-accurate GNSS/GPS technology. Its core products include Piksi Multi, a multi-band, multi-constellation high-precision GNSS receiver with seconds-level convergence, and Duro, a ruggedized version for harsh outdoor deployments. The company serves over 2,000 customers across autonomous vehicles, precision agriculture, UAVs, robotics, maritime, transportation/logistics and outdoor industrial applications. In June 2017 it raised $34M in a Series B, bringing total funding to $47.6M. Swift plans to use the funds to scale customer deployments, grow its team, and invest in core engineering and R&D. It also intends to introduce additional next-generation products in 2017. Swift Navigation develops accurate Real Time Kinematics (RTK) GPS positioning technology for applications including unmanned aerial vehicles, precision agriculture, self-driving cars, robotics and surveying. Led by CEO Tim Harris, the company has sold its first product, Piksi™, to over 1,200 customers. Swift is planning to introduce two next-generation products in 2016. Financially, the company has raised a total of $13.6M to date. The firm intends to use new funding to scale and grow its team and to invest in core engineering and R&D.

Participated · Seed · Feb 2025

Founded in 2024 and based in Portland, OR, AheadComputing is developing a breakthrough CPU microarchitecture that marries RISC-V extensibility with proprietary design to maximize per-core performance for AI inference, agentic AI, and other data-center tasks. The 120-person team, which collectively holds hundreds of compute patents and has shipped more than 70 products in prior roles, is currently building its first high-performance general-purpose CPU. The company positions its architecture as a critical complement to GPUs, arguing that CPU performance is still essential as 70% of data-center workloads are expected to be AI-related by 2030. Proceeds from recent funding are earmarked for R&D, software innovation, and test-chip development, as well as continued team expansion. Key technical collaborations include Alchip, Cadence, Skyechip, and Tenstorrent. To date, the company has raised $53 million, giving it runway to bring its initial product to market and further integrate RISC-V into mainstream AI infrastructure.

Participated · Series A · Mar 2024

Zephyr AI, based in McLean, Va., develops fast, explainable artificial intelligence and data-federation tools to advance precision medicine in oncology and cardiometabolic disease. The company is building improved data federation capabilities and machine learning algorithms and is deploying one of the largest clinicogenomic datasets spanning multiple disease states and data partners. Zephyr AI says it will use the new capital to enhance analytical speed and to fortify its training and validation datasets. The funds will also support expansion of the company’s scientific and commercial teams to accelerate delivery of its growing pipeline of insights to market. The team combines software engineers and biologists to generate translatable insights and build tools for patients, providers, and researchers. Zephyr AI has had two abstracts accepted for presentation at the AACR annual meeting in April 2024. Zephyr AI develops a proprietary suite of AI and data-science technologies that ingest complex, disparate healthcare data to generate translatable insights for precision medicine and drug discovery. The company emphasizes a three‑pronged approach: multi‑dimensional datasets, transparent AI, and analyses within structured biological networks and longitudinal outcomes. Since its founding in 2021 by Red Cell Partners, Zephyr has built a multidisciplinary team of data scientists, software engineers, and computational and molecular biologists. Zephyr prioritizes industry partnerships to access and maximally utilize broad healthcare datasets. The company aims to produce tools and products to support patients and providers, with focus areas including diabetes and cancer. Financially, Zephyr closed an $18.5 million seed round to expand dataset curation, refine machine‑learning models, and derive actionable insights for patient care and drug discovery.

Led · Series B · Mar 2022

Spotlight Therapeutics develops cell-targeted in vivo CRISPR gene-editing biologics using its proprietary TAGE (Targeted Active Gene Editors) platform. TAGE comprises highly engineered, modular programmable CRISPR effectors designed to target and edit selected cell types in vivo, avoiding the complexity of viral, viral-like, and nanoparticle delivery systems. The approach aims to expand applications and increase patient access, with the aspiration of enabling effective one-and-done medicines. Spotlight is advancing a pipeline toward clinical studies with programs in immuno-oncology, ophthalmic diseases, and hemoglobinopathies. Founded in mid-2018 and headquartered in Hayward, California, the company announced a $36.5M Series B to fund progression toward the clinic. Recent promotions and executive hires (CSO, Executive Director of Technology, VP Corporate and Business Development) support its push to execute development plans and establish strategic partnerships. Spotlight Therapeutics develops programmable CRISPR ribonucleoproteins (RNPs) and a proprietary TAGE platform to enable direct in vivo, cell-targeted gene editing using a modular biologics approach. The platform is designed to avoid complexities and toxicities associated with cell, viral, and nanoparticle delivery methods. The company is advancing lead programs in hemoglobinopathies and immuno-oncology toward clinical studies. Spotlight emphasizes integrating CRISPR editing with established biologics precepts to expand therapeutic applications. Leadership includes CEO Mary Haak-Frendscho and industry veterans Mary Janatpour and Hari Jayaram, and the company was co-founded by Alex Marson, Jacob Corn, and Patrick Hsu. Its scientific advisory board features Carolyn Bertozzi, Ronald Levy, and Jim Wells. Spotlight is headquartered in Hayward, California and was established in mid-2018. The company recently completed a financing round to support its pipeline advancement.

Participated · Series C · Feb 2022

Epirus develops counter-drone systems centered on its Leonidas platform, which beams high-powered electromagnetic pulses at drones as it moves across the battlefield. The company has won multiple U.S. military contracts, including a $66 million Army deal awarded in 2023. Epirus plans to use new funding to expand into international and commercial markets, grow its team, improve supply chain resiliency, and open a simulation center in Oklahoma to train soldiers. Financially, Epirus has raised an oversubscribed $250 million Series D and says its valuation is over $1 billion. The firm was previously valued at $1.35 billion after a $200 million Series C in 2022, and Bloomberg reported the new round was being raised at a lower valuation than that Series C. To date, Epirus has raised more than $550 million in total. Epirus designs solid‑state, software‑defined directed energy systems and a machine‑intelligent SmartPower platform to optimize power efficiency in defense and commercial applications. Its flagship Leonidas high‑power microwave (HPM) system and the portable Leonidas Pod create a layered counter‑electronics capability against hostile drones and electronic threats. The company has multiple product lines in development and says recent DARPA and Army Applications Laboratory contracts validate its defense market traction. In the past year Epirus more than doubled its workforce and opened a Corporate Headquarters in Torrance, California to support accelerated growth. Founded in 2018, Epirus emphasizes rapid innovation and plans to expand its team and commercial applications for its technology. Financially, the company announced a $200 million Series C, bringing total financing to date to $287 million and valuing the business at $1.35 billion. Epirus builds software-defined high-powered microwave (HPM) products and directed-energy systems, with SmartPower power-management technology at the center of its product roadmap. The company is bringing its flagship Leonidas C-UAS system to market in early 2021 and is developing additional directed-energy solutions for defense and commercial markets. Epirus has a strategic supplier agreement with Northrop Grumman to provide an EMP capability as a component of Northrop Grumman’s C-UAS systems-of-systems offering. L3Harris Technologies is partnering with and investing in Epirus to create greater power efficiencies within some of its systems. The company has expanded its footprint with an office in Tysons Corner and plans to hire roughly 100 roles in 2021 and double headcount again in 2022, with further expansion across Los Angeles, Virginia, and the Midwest. Recent financings support its manufacturing and scale-up plans for SmartPower and other products.